Improved survival ends nivolumab trial early
- PMID: 25185170
- DOI: 10.1158/2159-8290.CD-NB2014-104
Improved survival ends nivolumab trial early
Abstract
A phase III trial testing nivolumab to treat advanced melanoma was stopped early due to improved overall survival compared with standard chemotherapy.
©2014 American Association for Cancer Research.
Comment on
-
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.J Clin Oncol. 2014 Apr 1;32(10):1020-30. doi: 10.1200/JCO.2013.53.0105. Epub 2014 Mar 3. J Clin Oncol. 2014. PMID: 24590637 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
